Calamos Advisors LLC United Therapeutics Corp Transaction History

Calamos Advisors LLC

  • $16.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023
BUY
$205.95 - $280.43 $625,470 - $851,665
3,037 Added 103.05%
5,984 $0
Q3 2022

Oct 24, 2022
BUY
$203.3 - $244.17 $146,579 - $176,046
721 Added 32.39%
2,947 $617,000
Q2 2022

Aug 01, 2022
BUY
$174.81 - $241.14 $389,127 - $536,777
2,226 New
2,226 $525,000

Others Institutions Holding UTHR

# of Institutions
676
Shares Held
42.1M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email